Polymorphisms and mutations in the TDGF1 locus have been linked to different medical conditions and assessing the TDGF1 genetic status was shown to improve cancer patients’ risk stratification, as well as produce information about potential genetic disorders [2,112,113]. The gene discussed is CRIPTO; the disease is cancer.